The effects of calcium phosphate cement particles on osteoblast functions

被引:128
作者
Pioletti, DP
Takei, H
Lin, T
Van Landuyt, P
Ma, QJ
Kwon, SY
Sung, KLP
机构
[1] Univ Calif San Diego, Dept Orthopaed, La Jolla, CA 92093 USA
[2] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA
[3] Swiss Fed Inst Technol, Dept Mat Sci, CH-1015 Lausanne, Switzerland
[4] Univ Calif San Diego, Whitehead Inst Biomed Res, La Jolla, CA 92093 USA
关键词
osteoblast functions; calcium phosphate cement particles;
D O I
10.1016/S0142-9612(99)00250-1
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Calcium phosphate cements (CPC) are increasingly used in the orthopedic field. This kind of cement has potential applications in bone defect replacements, osteosynthetic screw reinforcements or drug delivery. In vivo studies have demonstrated a good osteointegration of CPC. However, it was also observed that the resorption of CPC could create particles. It is known from orthopedic implant studies that particles can be responsible for the peri-implant osteolysis. Biocompatibility assessment of CPC should then be performed with particles. In this study, we quantified the functions of osteoblasts in the presence of beta-TCP, brushite and cement particles. Two particle sizes were prepared. The first one corresponded to the critical diameter range 1-10 mu m and the second one had a diameter larger than 10 mu m. We found that CPC particles could adversely affect the osteoblast functions. A decrease in viability, proliferation and production of extracellular matrix was measured. A dose effect was also observed. A ratio of 50 CPC particles per osteoblast could be considered as the maximum number of particles supported by an osteoblast. The smaller particles had stronger negative effects on osteoblast functions than the larger ones. Future CPC development should minimize the generation of particles smaller than 10 mu m. (C) 2000 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1103 / 1114
页数:12
相关论文
共 46 条
[31]  
Pioletti DP, 1999, J BIOMED MATER RES, V46, P399, DOI 10.1002/(SICI)1097-4636(19990905)46:3<399::AID-JBM13>3.3.CO
[32]  
2-2
[33]   OSTEOBLAST RESPONSES TO ORTHOPEDIC IMPLANT MATERIALS INVITRO [J].
PULEO, DA ;
HOLLERAN, LA ;
DOREMUS, RH ;
BIZIOS, R .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH, 1991, 25 (06) :711-723
[34]  
Shanbhag AS, 1998, J BIOMED MATER RES, V41, P497, DOI 10.1002/(SICI)1097-4636(19980905)41:3<497::AID-JBM21>3.0.CO
[35]  
2-E
[36]   OSTEOBLASTIC CELLS FROM RAT LONG-BONE .1. CHARACTERIZATION OF THEIR DIFFERENTIATION IN CULTURE [J].
STRINGA, E ;
FILANTI, C ;
GIUNCIUGLIO, D ;
ALBINI, A ;
MANDUCA, P .
BONE, 1995, 16 (06) :663-670
[37]  
Sun JS, 1997, J BIOMED MATER RES, V37, P324, DOI 10.1002/(SICI)1097-4636(19971205)37:3<324::AID-JBM3>3.0.CO
[38]  
2-N
[39]  
TAKEI H, 2000, IN PRESS J ORTHOP RE
[40]  
Van Landuyt P, 1997, BIOCERAMICS, V10, P477